EPQ LLC CTYM PS 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 5:28 pm Sale |
2022-12-31 | 13G | Quince Therapeutics, Inc. QNCX |
EPQ LLC CTYM PS | 1,576,720 4.400% |
-1,286,376 (-44.93%) |
Filing |
| 2021-02-01 4:25 pm Purchase |
2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX |
EPQ LLC CTYM PS | 2,863,096 9.710% |
36,300 (+1.28%) |
Filing |